Cargando…

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma

Metastatic disease is linked to TERT promoter mutations in conjunctival melanomas (CM). Both TERT promoter and ATRX mutations are associated with faulty telomere maintenance. This study aimed to determine the prognostic value of ATRX loss in conjunctival melanocytic lesions. Eighty-six conjunctival...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Ipenburg, Jolique A., van den Bosch, Quincy C. C., Paridaens, Dion, Dubbink, Hendrikus J., Kiliç, Emine, Naus, Nicole, Verdijk, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454703/ https://www.ncbi.nlm.nih.gov/pubmed/37629169 http://dx.doi.org/10.3390/ijms241612988

Ejemplares similares

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
por: van Poppelen, Natasha M., et al.
Publicado: (2021)

Absence of Intraocular Lymphatic Vessels in Uveal Melanomas with Extrascleral Growth
por: van Beek, Jackelien G. M., et al.
Publicado: (2019)

FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma
por: van den Bosch, Quincy C. C., et al.
Publicado: (2022)

Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
por: van den Bosch, Thomas, et al.
Publicado: (2010)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Pals, Jan, et al.
Publicado: (2021)

Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma
por: de Bruyn, Daniël P., et al.
Publicado: (2022)

Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing
por: van Poppelen, Natasha M., et al.
Publicado: (2020)

Fractionated stereotactic radiotherapy for uveal melanoma: Long‐term outcome and control rates
por: van Beek, Jackelien G. M., et al.
Publicado: (2021)

Radiological Patterns of Uveal Melanoma Liver Metastases in Correlation to Genetic Status
por: Yavuzyigitoglu, Serdar, et al.
Publicado: (2021)

Uveal Melanoma Patients Have a Distinct Metabolic Phenotype in Peripheral Blood
por: de Bruyn, Daniël P., et al.
Publicado: (2023)

Transient Expression of Lymphatic Markers in Retrobulbar Intraconal Orbital Vasculature During Fetal Development
por: van den Bosch, Quincy C. C., et al.
Publicado: (2020)

Identification of Early-Onset Metastasis in SF3B1 Mutated Uveal Melanoma
por: Drabarek, Wojtek, et al.
Publicado: (2022)

High C-Reactive Protein Levels Are Related to Better Survival in Patients with Uveal Melanoma
por: Meijer, Nikki, et al.
Publicado: (2022)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

Chromosomal rearrangements in uveal melanoma: Chromothripsis
por: van Poppelen, Natasha M., et al.
Publicado: (2018)

Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
por: Koopmans, A E, et al.
Publicado: (2013)

SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?
por: van Poppelen, Natasha M., et al.
Publicado: (2019)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Prognosis of conjunctival melanomas in relation to histopathological features.
por: Fuchs, U., et al.
Publicado: (1989)

Conjunctival melanoma
por: de Abreu, Marilda Aparecida Milanez Morgado, et al.
Publicado: (2018)

Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis
por: Solomon, Lauren A., et al.
Publicado: (2013)

Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
por: Cao, Jinfeng, et al.
Publicado: (2018)

Decreased expression of the chromatin remodeler ATRX associates with melanoma progression
por: Qadeer, Zulekha A., et al.
Publicado: (2014)

Choroidal melanoma with synchronous Fuchs’ adenoma and novel ATRX mutation
por: Harford, Elli, et al.
Publicado: (2022)

Vision loss caused by immunoglobulin G4–related disease of the skull base complicated by a mucocele of the sphenoid sinus
por: Detiger, Sanne E., et al.
Publicado: (2022)

Loss of ATRX leads to chromosome cohesion and congression defects
por: Ritchie, Kieran, et al.
Publicado: (2008)

Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1(R132H) mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss
por: Cai, Hong-Qing, et al.
Publicado: (2018)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
por: Gaspar, Tiago Bordeira, et al.
Publicado: (2022)

Loss of ATRX in Chondrocytes Has Minimal Effects on Skeletal Development
por: Solomon, Lauren A., et al.
Publicado: (2009)

Cellular and molecular mechanisms of neuronal loss in Atrx-knockout mice
por: Lagali, Pamela S, et al.
Publicado: (2013)

Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.
por: Zalenski, Abigail A, et al.
Publicado: (2021)

Synchronous conjunctival melanoma and lentigo maligna melanoma
por: Volpini, Beatrice Mussio Fornazier, et al.
Publicado: (2017)

NF1 mutations in conjunctival melanoma
por: Scholz, S. L., et al.
Publicado: (2018)

Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis
por: Cohen, Victoria M. L., et al.
Publicado: (2019)

Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
por: Zimmermann, P, et al.
Publicado: (2009)

Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
por: Udugama, Maheshi, et al.
Publicado: (2018)

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
por: Garbarino, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt68fnq6n89aippm4c7k2koufm